Solazyme (SZYM -17.8%) sinks following news it will dissolve its joint venture with Roquette Frères after failing to agree on a commercial strategy and timeline for the manufacturing and marketing of the venture's products. SZYM says it will accelerate commercialization of its own suite of microalgal food ingredients. At least two firms say today's selloff on the news is an overreaction.
Solazyme (SZYM -17.8%) sinks following news it will dissolve its joint venture with Roquette...
From other sites
at CNBC.com (Mar 25, 2014)
at CNBC.com (Mar 7, 2014)
at CNBC.com (Jan 13, 2014)
at CNBC.com (Mar 7, 2013)
at CNBC.com (Jan 4, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs